Met Life Investment Management, LLC Pulmonx Corp Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 22,244 shares of LUNG stock, worth $135,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,244
Previous 22,244
-0.0%
Holding current value
$135,910
Previous $141,000
30.5%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding LUNG
# of Institutions
126Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$34.7 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$23.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$13.9 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.34 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $228M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...